Every day, billions of dollars’ worth of medications move through the global pharmaceutical supply chain, from manufacturers and distributors to pharmacies, hospitals, infusion centers, and clinical care environments. As therapies become more specialized, temperature-sensitive, and operationally complex, healthcare organizations are under increasing pressure to maintain tighter control, visibility, and accountability across the entire medication supply chain.
That challenge was brought into focus recently after reports that an open freezer door contributed to the loss of approximately $20 million worth of medications, vaccines, and emergency response supplies within Canada’s national emergency stockpile. While the scale of the incident made headlines, the underlying issue is far broader than a single event. Across healthcare, organizations continue to manage critical pharmaceutical inventory through fragmented systems, delayed visibility, and manual workflows that were never designed for the complexity and precision required by today’s modern therapies.
Managing inevitable issues
How can a lapse as simple as a freezer door being left open lead to such a costly loss? Hospitals and pharmacies work incredibly hard to protect medication inventory and maintain proper storage conditions, accountability, and oversight. But in many organizations, the systems supporting those efforts are still fragmented and heavily dependent on manual processes.
Environmental monitoring, inventory management, pharmacy workflows, access controls, and supply chain systems often operate independently from one another. In many cases, notifications are routed through multiple people and escalation paths before the right team is even aware an issue exists. All it takes is one missed alert, delayed response, or workflow breakdown for a situation to escalate into significant inventory loss.
When temperature excursions are not identified immediately, organizations are often forced into reactive investigations. Teams may need to determine how long products were outside acceptable ranges, whether inventory can still be used, and what products may need to be discarded or short-dated. With many specialty medications, biologics, oncology therapies, and compounded products carrying extremely high replacement costs and limited availability, the operational and financial consequences can be substantial.
These challenges become even more difficult during periods of drug shortages or allocation constraints, where replacement inventory may not be readily available. In these situations, the issue extends beyond cost alone. Maintaining continuity of supply becomes a critical operational priority.
Moving beyond fragmented visibility
Healthcare’s inventory infrastructure was largely designed around high-volume medication distribution, not the level of precision now required for modern specialty pharmaceuticals and high-value therapies.
Today, many organizations still rely heavily on barcode-based workflows to manage inventory movement and accountability. Although barcode systems improved traceability significantly over the past several decades, they remain dependent on manual scans and human interaction. If an item is not scanned, the system has limited awareness of where inventory is located, whether it has moved, or what conditions it may have experienced.
That becomes increasingly difficult to manage when hospitals are overseeing thousands of medications across pharmacies, refrigerators, procedural environments, infusion centers, decentralized storage areas, and distributed health system networks.
This is where connected inventory infrastructure and RFID-enabled visibility become increasingly important.
With RFID-enabled systems, organizations can gain continuous visibility into medication location, inventory status, expiration data, environmental conditions, and inventory movement throughout the supply chain. Rather than relying on fragmented systems and delayed manual reconciliation, organizations can operate from a more connected and interoperable infrastructure model.
That visibility becomes especially important for refrigerated and specialty medications. If a temperature excursion occurs, operational teams need immediate clarity into exactly what inventory was affected, how long conditions were compromised, and what actions need to be taken. Without connected visibility, teams are often forced into time-consuming manual investigations during already stressful situations.
Connected visibility also improves inventory awareness across refrigerators, cabinets, pharmacies, and procedural areas. Instead of relying on periodic manual counts or assumptions about inventory location and availability, organizations can maintain more accurate, real-time awareness of what inventory they have, where it is located, and how it is moving throughout the organization.
Visibility across the broader supply chain
The medication supply chain is becoming increasingly interconnected, and manufacturers are under growing pressure to improve traceability, inventory intelligence, and operational responsiveness across distribution networks. Source-tagging medications at manufacturing using interoperable GS1 standards creates the foundation for broader end-to-end visibility throughout the supply chain.
Several pharmaceutical manufacturers have already begun moving in this direction. Pfizer has utilized RFID-enabled approaches to support product authentication initiatives, while Fresenius Kabi offers portions of its portfolio with RFID-enabled tagging aligned to GS1 standards. Because these efforts follow interoperable GS1 standards, they can work across broader healthcare ecosystems rather than within isolated proprietary environments.
This interoperability will become increasingly important as regulatory expectations and operational complexity continue to grow. In the United States, the Drug Supply Chain Security Act (DSCSA) continues pushing the industry toward more interoperable electronic supply chain infrastructure. At the same time, health systems are facing mounting pressure to reduce waste, manage shortages more effectively, improve inventory governance, and operate with tighter financial discipline.
There is also a larger operational intelligence opportunity emerging. Modern supply chain visibility creates the potential for manufacturers and providers to better understand inventory movement, utilization patterns, allocation needs, seasonal demand fluctuations, and replenishment timing using aggregated real-time inventory insights rather than static historical assumptions. That level of visibility could significantly improve how organizations plan production, manage shortages, allocate supply, and reduce unnecessary inventory waste across the healthcare ecosystem.
A necessary transition
Other industries have operated with real-time logistics visibility and connected supply chain intelligence for years. Healthcare, despite managing some of the world’s most valuable and operationally critical inventory, still often operates with fragmented visibility and delayed awareness. That model is becoming increasingly difficult to sustain.
The healthcare industry is approaching a point where disconnected inventory systems, manual reconciliation processes, and limited real-time visibility are no longer operationally sufficient for the complexity of modern medication management. Organizations that modernize inventory visibility and build more connected, interoperable infrastructure will be better positioned to manage cost pressures, supply continuity, operational resilience, and the growing complexity of the pharmaceutical supply chain in the years ahead.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
